Search results
Results from the WOW.Com Content Network
Tuberculosis is one of India's biggest health issues, but what makes this problem even worse is the recent discovery of Totally Drug-Resistant Tuberculosis, TDR-TB. This issue of drug resistance began with MDR-TB , moved to XDR-TB and, as of 2021, has grown to embrace the most dangerous form, TDR-TB .
In India a sizable proportion of the people with symptoms suggestive of pulmonary tuberculosis approach the private sector for their immediate health care needs. However, the private sector is overburdened, and lacks the capacity to treat such high volumes of patients.
Roughly one-quarter of the world's population has been infected with M. tuberculosis, [6] with new infections occurring in about 1% of the population each year. [11] However, most infections with M. tuberculosis do not cause disease, [169] and 90–95% of infections remain asymptomatic. [87] In 2012, an estimated 8.6 million chronic cases were ...
The institute provides postgraduate training for the students of Diploma in Tuberculosis and Chest Diseases (DTCD), Doctor of Medicine (MD, Chest), FCPS, MS, and also undergraduate teaching in tuberculosis for the students of different medical colleges. [6] Skyline of NIDCH
The Institute of Epidemiology, Disease Control And Research (IEDCR) (Bengali: রোগতত্ত্ব, রোগ নিয়ন্ত্রণ ও গবেষণা ইনস্টিটিউট) is a Bangladesh government research institute, under the Ministry of Health, responsible for researching epidemiological and communicable disease in Bangladesh as well as disease control.
The National Tuberculosis Institute (NTIB) [1] is a Government of India institute, under the Directorate General of Health Services, Ministry of Health and Family Welfare, dedicated to advanced research on Tuberculosis.
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.